Plasmodium Immunotherapy is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Colorectal Cancer.

The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...

Jimmy Carter’s 2015 melanoma diagnosis introduced the world to immunotherapy, sparking future cancer research. Millions of ...

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

The Health Route highlights Cape Coral, Florida, which has emerged as a hub in the healthcare sector, attracting medical ...

R3 new logo R3 Stem Cell is offering highest grade immunotherapy with Natural Killer Cells in Tijuana Mexico. The immu ...

OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that its Chair & CEO Paul Romness has accepted ...